Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Ingenuity extends software agreement with GSK
April 2008
SHARING OPTIONS:

REDWOOD CITY, Calif.Ingenuity Systems, a provider of information solutions for life science researchers, has extended and expanded its existing license agreement with GlaxoSmithKline for access to Ingenuity Pathways Analysis (IPA) software. The new agreement enables GSK to provide enterprise-wide IPA access to researchers for rapid assessment of the signaling and metabolic pathways, molecular networks and biological processes that are most significant to disease targets. "Many discovery programs at GSK have already successfully used IPA to understand the complex relationship between pathways and disease," says Jake Leschly, CEO, Ingenuity Systems. "Research teams across the organization will now be able to use these insights to make effective decisions as to which drug targets and compounds to pursue."






 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
478 Bay Street, Suite A213
Midland, Ontario, Canada L4R 1K9
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.